Chemotherapy for Ovarian Cancer: 133 Real Stories

133 stories match ovarian cancer and chemotherapy. 121 of them mention surgery.

A patient, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage IIIC Ovarian Cancer Found During Preoperative Screening

Patient Info: Anonymized, Female | Stage III

Biomarkers: BRCA1 pathogenic variant on homologous recombination deficiency testing; germline BRCA1 pathogenic variant

At approximately 1 year after surgery, she was alive without evidence of recurrence while continuing olaparib and bevacizumab maintenance therapy.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Growing Masses After Chemotherapy for an Ovarian Germ Cell Tumor

Patient Info: Anonymized, Female, Under 40

Biomarkers: AFP 581.2 ng/mL and CA-125 74.3 U/mL after surgery

Despite 6 chemotherapy cycles and normalization of AFP, abdominal and pelvic masses continued to grow while CA-125 and CEA increased. She sought a second opinion and underwent imaging and biopsy of an abdominal mass.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Recurrent Malignant Ovarian Steroid Cell Tumor Treated With Multiple Therapies

Patient Info: Anonymized, Female

Biomarkers: PIK3CA, and ATM mutations; ER negative; PR negative

She experienced repeated pelvic and lung recurrences. Platinum-based treatment produced a complete PET-CT response and olaparib maintenance provided about 1 year without progression before a 5 mm lung recurrence was surgically removed.

PubMed Central
OutcomeLiving With Cancer
Mimi, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III BRCA Ovarian Cancer: Mimi's Survivor Story

Patient Info: Mimi Gallagher, 40s | Stage III

Biomarkers: BRCA-positive

Mimi was cancer-free after surgery and 4 months of intraperitoneal chemotherapy, completed in December 2012.

Dana-Farber
OutcomeCancer-Free / NED
Faye, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Faye's Patient Story

Patient Info: Faye Belvin, Female

Faye was still receiving the trial combination and said the treatment was working and that she felt better than she had in the previous 2 years.

AACR
OutcomeResponding Well
A patient, who was diagnosed with Ovarian AdenocarcinomaOvarian Cancer

Recurrent Ovarian Cancer and Olaparib-Related Skin Toxicity

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|liver

The latest chemotherapy was effective, and she was alive without signs of another recurrence at the last documented follow-up.

PubMed Central
OutcomeCancer-Free / NED
Karen, who was diagnosed with Stage III Ovarian CancerOvarian Cancer

Stage III Ovarian Cancer: Karen's Survivor Story

Patient Info: Karen Howley LaCamera, 50s | Stage III

The REGN4018 clinical trial put Karen’s ovarian cancer into remission, which had lasted nearly a year when the story was written, with follow-up every 6 weeks.

Dana-Farber
OutcomeCancer-Free / NED
Mary, who was diagnosed with Ovarian CancerOvarian Cancer

BRCA1 Ovarian Cancer: Mary's Patient Story

Patient Info: Mary Anne Marshall, female

Biomarkers: BRCA1 mutation

She completed a difficult 2-year ovarian cancer treatment course and was alive 4 years into her combined cancer journey.

MD Anderson
OutcomeNot reported
A patient, who was diagnosed with Ovarian AdenocarcinomaOvarian Cancer

Ovarian Cancer Metastasis to the Cervical Spinal Canal

Patient Info: Anonymized, Female, 70+ | Stage Metastatic/Advanced

Metastatic Site: brain|cervical intradural extramedullary space

Her neck and shoulder pain resolved after spinal surgery, but she developed recurrent brain disease and died from cachexia 4 months after the spinal operation.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Granulosa Cell Tumor Recurring 17 Years After Surgery

Patient Info: Anonymized, Female, 70+

Biomarkers: Weak oestrogen sensitivity

Complete resection was not possible, but debulking relieved pressure on surrounding structures and improved her quality of life. She then continued oncology care with palliative carboplatin and paclitaxel.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Metastatic Clear Cell Ovarian Cancer Complicated by Treatment-Related Sarcoidosis

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Metastatic Site: peritoneum

During a treatment holiday, biopsy and laboratory evaluation showed treatment-related sarcoidosis rather than ovarian-cancer spread in the enlarged lymph nodes. After prednisone, the sarcoidosis resolved and imaging showed no progression of the clear cell ovarian cancer; she remained clinically well 4 months later.

PubMed Central
OutcomeStable Disease
Christie, who was diagnosed with Ovarian CancerOvarian Cancer

BRCA Ovarian Cancer: Christie's Patient Story

Patient Info: Christie Siebel, female

Biomarkers: BRCA mutation

At the latest update, Christie was doing well and having a CA125 blood test every 3 months for ovarian cancer follow-up.

MD Anderson
OutcomeCare Ongoing
IO
Ovarian Cancer

Immature Ovarian Teratoma Followed by Anti-NMDAR Encephalitis

Patient Info: Anonymized, Female

Biomarkers: AFP 67.6 ng/mL; CA-125 89 at presentation

After 4 cycles of chemotherapy, her neurological deficits fully recovered and she could walk independently, with mild stuttering improving through speech therapy.

PubMed Central
OutcomeNot reported
Shelley, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Shelley's Patient Story

Patient Info: Shelley O’Keefe, female

Shelley was nearing the end of chemotherapy, rebuilding her strength, and returning to demanding golf activity with strong family and community support.

Ovarian Cancer Research Alliance
OutcomeCare Ongoing
Dana, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Dana's Patient Story

Patient Info: Dana Kivel, female

Dana was living with recurrent, metastatic granulosa cell ovarian cancer and taking an aromatase inhibitor for a current tumor.

Ovarian Cancer Research Alliance
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Ovarian CancerOvarian Cancer

Stage 4 Ovarian Cancer Discovered During Trigeminal Neuralgia Evaluation

Patient Info: Anonymized, Female, 50s | Stage IV

Three months after surgery, she had recovered well from debulking and 6 total chemotherapy cycles, with complete macroscopic clearance achieved at surgery. Trigeminal-neuralgia symptoms persisted and continued to require daily medication.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Ovarian AdenocarcinomaOvarian Cancer

Kidney Complications After Treatment for Stage IV Ovarian Cancer

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: peritoneum|left lymph node

No further ovarian-cancer progression was observed during the 10 months after kidney biopsy. The nephrotic syndrome reached partial remission after immunosuppressive treatment was stopped and supportive care continued.

PubMed Central
OutcomeStable Disease
A patient, who was diagnosed with Ovarian CancerOvarian Cancer

Aggressive Presumed Ovarian Solid Pseudopapillary Tumor With Widespread Metastases

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|pelvic soft tissue|inguinal lymph…

The disease progressed rapidly across multiple abdominal and nodal sites. She died from disease-related complications 2 months after the oncology consultation while receiving induction chemotherapy.

PubMed Central
OutcomeIn Memory
Lauren, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Lauren's Survivor Story

Patient Info: Lauren Wells, Female, Under 40

Lauren was described as cancer-free and making a strong recovery while continuing physical, occupational, and speech therapy.

Cleveland Clinic
OutcomeCancer-Free / NED
Elle, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Elle's Patient Story

Patient Info: Elle Simone, female

Elle was dealing with an ovarian cancer recurrence while continuing her work and advocacy.

Ovarian Cancer Research Alliance
OutcomeSetback / Progression